指南与共识慢性肾脏病肾小球疾病

建立常染色体显性多囊肾病核心结局指标集:SONG-PKD共识研讨会报告

Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
指南 / 共识 · Am J Kidney Dis · 2020-08-06

常染色体显性多囊肾病(ADPKD)试验常忽略患者、临床医生和监管者关心的结局,限制了共享决策。最终确立肾功能、死亡率、心血管疾病和疼痛为ADPKD的核心结局。

要点

  • ADPKD试验核心结局为肾功能、死亡率、心血管疾病和疼痛。
  • 研讨会识别了轨迹与肾功能影响、疼痛特异性、ADPKD后果及罕见危及生命风险四个主题。
  • 核心结局集旨在统一ADPKD试验报告,促进共享决策。

核心结论

  • 肾功能、死亡率、心血管疾病和疼痛被确立为ADPKD的核心结局。

主要发现

  • 研讨会形成四个主题:轨迹与肾功能影响的相关性、ADPKD特异性疼痛的识别与定义、强调ADPKD后果、罕见危及生命后果的风险。

关键数值与推荐

  • 核心结局包括肾功能、死亡率、心血管疾病和疼痛。

临床怎么用

  • 在ADPKD临床试验和临床决策中,应优先考虑并报告肾功能、死亡率、心血管疾病和疼痛这些核心结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The omission of outcomes that are of relevance to patients, clinicians, and regulators across trials in autosomal dominant polycystic kidney disease (ADPKD) limits shared decision making. The Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Initiative convened an international consensus workshop on October 25, 2018, to discuss the identification and implementation of a potential core outcome set for all ADPKD trials. This article summarizes the discussion from the workshops and the SONG-PKD core outcome set. Key stakeholders including 11 patients/caregivers and 47 health professionals (nephrologists, policy makers, industry, and researchers) attended the workshop. Four themes emerged: "Relevance of trajectory and impact of kidney function" included concerns about a patient's prognosis and uncertainty of when they may need to commence kidney replacement therapy and the lack of an early prognostic marker to inform long-term decisions; "Discerning and defining pain specific to ADPKD" highlighted the challenges in determining the origin of pain, adapting to the chronicity and repeated episodes of pain, the need to place emphasis on pain management, and to have a validated measure for pain; "Highlighting ADPKD consequences" encompassed cyst-related complications and reflected patient's knowledge because of family history and the hereditary nature of ADPKD; and "Risk for life-threatening but rare consequences" such as cerebral aneurysm meant considering both frequency and severity of the outcome. Kidney function, mortality, cardiovascular disease, and pain were established as the core outcomes for ADPKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Cho Y, Tong A, Craig JC, et al. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop. Am J Kidney Dis. 2020. PMID: 32771648. doi:10.1053/j.ajkd.2020.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。